As new details emerge about the newly passed $900 billion coronavirus relief package, US public health officials are welcoming the added resources for delivering the vaccine and shoring up other pandemic response activities.And in global developments, the head of BioNTech said the vaccine it developed with Pfizer likely protects against the UK SARS-CoV-2 variant, as the virus pushed its way to Antarctica for the first time.Stimulus boost for public health responseDespite the speed of vaccine development and emergency use approval, public health officials have warned that they lack the resources to develop and staff mass immunization campaigns needed to help make the best use of the new tool for battling COVID-19.